A new study suggests that HIV infected patients should start antiretroviral treatment earlier. Here’s the editor’s note accompanying the article in today’s online version of the Lancet: “When to start antiretroviral treatment has been a problem for physicians dealing with patients with HIV infection. Most commonly the decision is based on CD4 counts, […]
The meeting in Beijing last week of health ministers from high-burden MDR and XDR TB countries has produced some significant results, at least on paper. Perhaps most notably, participants “committed to help mobilize $2 billion needed over the next two years to adequately finance the TB and M/XDR-TB response from both domestic and international resources […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]